← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2018-04-19

Drug application

FDA Application #
ANDA090457
Application type
Abbreviated New Drug Application (Generic)
Brand name
LAMIVUDINE
Generic name
LAMIVUDINE
Active ingredients
LAMIVUDINE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
STRIDES PHARMA
Manufacturer
Strides Pharma Science Limited
First approval
2018-04-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown